Louis Navellier has been around for far longer than most of the newsletter pundits, and his quantitative system has proven itself to be pretty good on average for long periods of time (though it also has taken big hits during rapid market collapses, of course) — we write about his teaser picks from time to […]
Articles
- Most Relevant
- Most Recent
Eric Fry is teasing us about the coming “A.I. Wars,” and the necessity of building more and more advanced AI-ready chips in the United States and reducing our reliance on Taiwan and South Korea, and the heart of his pitch is that some companies will see huge profit opportunities as semiconductor capital spending grows to […]
On days like today, I don’t have to spend much time deciding which of the dozens of teaser pitches we receive to cover — it’s unanimous, Gumshoe readers are crying out for a solution to the latest pitch from Dr. Kent Moors. Moors is an energy expert and Duquesne professor, and he sells the expertise […]
I’m starting with a quick teaser solution for you, since we’ve got more people asking about this latest James Altucher ad today than anything else. I’m not going to go through all the detail for you, due to a lack of time, but it seems like folks are feeling itchy about this one so we’ll […]
Yet another interesting week! Oh, how we miss the boring days, when everything just went up all the time. And it’s still, of course, all about inflation and the Federal Reserve. I would have guessed, like many people, that the CPI number would come in a bit worse than expected this month, given the persistence […]
Tidings, Mostly Glad[ed note: We feature the musings of our favorite health and medicine writer, Michael Jorrin, a couple times a month, and we’ve taken the liberty of calling him “Doc Gumshoe” (he’s not a doctor). You’ll find no stock picks in his pieces, but hopefully will get plenty of insight into the medical matters he explains […]
[Ed note: if you’re new to Doc Gumshoe, this is our break from investment chatter: He’s our favorite medical writer and he shares his contrarian and thoughtful commentaries with us every now and again. Any opinions and assertions are his own.] It all starts with an unassailable truth: the healthier you are to start with, […]
[Ed. Note: Dr. KSS writes about biotech and medicine for the Irregulars. He adheres to our trading restrictions, choses his own topics, and his words and opinions are his own. His past articles and most recent comments can be found at his Stock Gumshoe page.] Dr. Norchi called me at home this morning to provide […]
Curzio teased a little in his show last Friday about a company he went to New York for to do some boots on the groun research. He met with chief of police and spoke of a new weapon that he allowed the police department to demonstrate on him. A new non lethal restraining weapon that […]
[ed. note: Gumshoe readers have been delighted with the biotech stock discussion led by one of our readers, who has gone by the name karmaswimswami as he has shared hundreds of useful comments — so we’ve asked him to come on as a formal contributor, he’ll be sharing a column with the Irregulars and talking […]
Please reveal Larry Edelson’s 3 millionaire maker gold stocks,.I am one of your favorate people,
[Ed. Note: Dr. KSS writes about medicine biotech stocks for the Gumshoe Irregulars. He chooses his own topics, and his words and opinions are his own. Visit his Stock Gumshoe page for his past articles and most recent comments.] Assessing biotechnology stocks involves use of lots of mental microscopes and magnifying lenses. But the task […]
[ed note: Michael Jorrin, who I dubbed “Doc Gumshoe” a few years back, writes for us about health and medicine a couple times a month. He does not typically cover the investment side of medicine, but, as today, he often digs into the health “teasers” and hyperbole that we all see along with the investment […]
[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. His topics, words and opinions are his own. Enjoy!] It’s the second reel of conspiracy film Shooter, and Mark Wahlberg, whom government schemers are trying to frame for assassination, has just been shot twice. In the back of a stolen FBI car, […]
Here’s what I can’t tell you: Where the price of gold is going. Here’s what I can tell you: Over the past several weeks, as investor enthusiasm for gold clearly reached the melting point in a big price spike to near $900, I’ve seen almost every gold teaser in the book. Gold is down a bit again today, but the gold bugs are still out in force and certain that they will be vindicated when inflation and dollar devaluation finally rear their ugly heads. What do the experts say now?
The Resveratrol Bust Disappointing, but unsurprising, I say. At this point I’m willing to stake my bet that the wonderful promise of resveratrol isn’t going to pan out. What’s resveratrol? Let’s take a little journey back in our time machine About Resveratrol It goes back at least 70 years, to the discovery by Japanese investigators […]
In past times, what surgeons did was basically removing infected body parts and things that didn’t belong in our bodies, like tumors and foreign bodies. For most of the history of the practice of medicine, surgeons were admired for their manual dexterity rather than for their skill and intelligence in diagnosing and treating disease. The […]
This microblog is for stocks that do not fit neatly in http://www.stockgumshoe.com/2015/04/microblog-biotech-in-a-dr-kss-less-world/ or http://www.stockgumshoe.com/2015/04/microblog-biotech-by-hendrixnuzzles/. To get started, Thomas Kelly mentioned NVIV on the “……by-hendrixnuzzles blog “: “…. The Neuro-Spinal Scaffold is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord contusion. The Neuro-Spinal Scaffold provides […]
A pre-emptive tease: no newsletters are yet touting this company, but like many stocks that they do tease, it is small, cheap, almost unknown, and even has the exotic appeal of being Australian. Sort of. At Stock Gumshoe we not only deconstruct pitched stocks, we find teasable stocks before the newsletters do! Let’s return to […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for our Irregulars. He chooses his own topics, and his words and opinions are his own. He has agreed to our trading restrictions. Visit his Stock Gumshoe page for more.] Bacteria are prokaryotes. Animal cells, fungi and plants are eukaryotes. Prokaryotes tend to be acellular and […]
This past year of writing for the Gumshoe faithful has been a wonderful one for me, but not so much for the returns of the stocks that I singled out for extra attention here for the loyal Stock Gumshoe Irregulars. As I’ve noted before, starting this additional little service for my contributors has served mostly, […]
This past year of writing for the Gumshoe faithful has been a wonderful one for me, but not so much for the returns of the stocks that I singled out for extra attention here for the loyal Stock Gumshoe Irregulars. As I’ve noted before, starting this additional little service for my contributors has served mostly, […]
The good folks at Motley Fool’s Stock Advisor newsletter have another teaser for us … they think they’ve got a “virtually recession-proof” stock for you to buy … in their words: “On Sale Now… a Virtually Recession-Proof Business Poised for 100% Gains… “An investment story like this doesn’t come along very often… “It’s a business […]
“After 98 years of secrecy, the greatest economic conspiracy in history is finally unfolding.” “Learn how you could turn $5,000 into $100,000 (or more) by 2009 with this safe and simple profit/protection plan…” That’s how this latest ad opens, with the threat that the 98-year-old “Jeckyl Island Project” economic conspiracy will ruin your retirement — […]
Your friendly neighborhood Stock Gumshoe tends to focus on US-based investment newsletters and the hype they generate, but that’s not because this phenomenon is restricted to our fair shores. Newsletters and advisories proliferate around the world, even if the center of newsletter land continues to be the area within 100 miles or so of my […]
If you’re not an analyst or asset manager who specializes in the financial sector, and you don’t count on AIG, Lehman Brothers, or their many near competitors for a paycheck, right now might be a good time to take a step back, breathe a little, and thank whatever deity or lucky totem you might carry, […]
Today’s ad is yet another one that claims a newsletter editor can provide safe passage through the stormy shoals of government data, and lead you to the soft, warm beaches of the millionaires on the other side. It’s for Inside Strategist, a Stansberry and Associates publication that’s edited by a former FBI employee. Here’s how […]
My confidence in the long-term potential for Seadrill remains unshaken, but the price has certainly taken a hit in the last week (and the last two months). I think all the major offshore drillers are unbelievable bargains at this point, since they have fabulous earnings visibility out several years regardless of the oil price (these […]
Anyone who has been wandering around the halls here at Gumshoe University for any length of time will know that Georges Yared has been getting a heck of a push from the publisher of his new newsletter of late — if you haven’t gotten an ad for Game Changers, your spam filter is better than […]
It seems as though interest in China is again growing, after a Fall and Winter when even rabid China bulls like Robert Hsu were somewhat cautiously looking for “greater China” opportunities and China resource plays in places like Brazil and Australia. Now, it seems, China is cheap enough to be back on the radar — […]
This delightful ad has clearly graced many an inbox over the past few days — I know I’ve gotten it about a dozen times myself, not to mention the hundreds of Gumshoe readers who have also been kind enough to send it along. OK, dozens. Still. So the marketing push is on … … but, […]
This one is apparently a newsletter that’s new for US and European investors, but from an advisor who’s been doing research on commodities companies for Aussie subscribers for a number of years. The newsletter is called the Australian Resource and Mining Report, and it’s edited by Dan Denning, which we of course find out on […]
This is a teaser that many of you have already figured it out, but I’m still seeing it in heavy rotation so I thought I’d share … it’s from an ad for Karim Rahemtulla’s Xcelerated Profits Report, I don’t think we’ve looked at his stuff since their fabulous ad for “Dark Equities” a few months […]
This one’s from Christian DeHaemer for Material Profit, one of the “introductory” inexpensive newsletters from Taipan (on sale for $49 at the moment, apparently). This group is no stranger to your friendly neighborhood Gumshoe, but I don’t think I’ve looked at one from Material Profit before (I’ve looked at many from DeHaemer’s other services, most […]
Hello out there, happy investors of Gumshoe Land! For your pleasure this weekend I thought I’d revisit a couple old teasers that have been making the rounds again, since the emails about them have been piling up and, in some cases, the companies may have gotten more or less interesting. The first one is the […]
I was just settling down for a nice teaser read from our friends at Stansberry and Associates — this time teasing the relatively new Advanced Income newsletter from Jeff Clark. And it started to sound a little bit familiar … “It’s the world’s best income secret, perfected by a California Millionaire over the past 20 […]
This teaser comes in with Navellier happily boasting that his strategy is on the ascent — that value managers are headed for the exits and growth managers are shooting out the lights … which does certainly appear to be the conventional wisdom these days (value managers, after all, are almost all stuck with huge positions […]
This one has been floating around for a month or so, and I did write briefly about it when it was being touted as the supplier that would take a 50% leap on iPhone sales (that was back in October). This is a teaser that came in from Ann Sosnowski at Diligent Investor, who spins […]
Another one that’s partially from the archives: Navellier has been sending out a teaser mentioning seven “Million Dollar Machines” that he thinks are great investments right now. This whole “Million Dollar Machine” concept was one he trotted out over the Summer, too and apparently it was pretty successful (why else would we be seeing it […]
Don’t worry, this is not about turtle soup, or about chopping up leatherbacks and making acne cream out of them … this is about a whole different kind of sea turtle. The “Hai Gui” or “sea turtles” of China are the returning scientists and businessmen that are driving, in part, the resurgence of the Chinese […]